Financial Assistance
Newsletter Sign-up
Need Appointment
Contact Us
About Us

Rush University
For Physicians
For Rush Employees
For Students
Bill Payment Center
Rotate
<< Previous | New Search | Return to Search Results | Next >>

Robert Aiken, MD

Robert Aiken, MD
Appointment Request

Or call
(888) 352-RUSH for help arranging an appointment.
Specialty:
  • Neurology
Board Certification:
  • Neurology
Faculty Rank: Associate Professor
Medical or Graduate Education: Wayne State University School of Medicine
Residency: Baylor College of Medicine - Internal Medicine
  Neurological Institute of New York, Columbia University - Neurology
Fellowship: Memorial Sloan-Kettering Cancer Center - Neuro-Oncology
Clinical Expertise:
  • Brain tumor
  • Meningioma
  • Neuro-oncology
Research Interests:
  • Clinical trials of therapies for brain tumors
  • Developmental therapeutics
  • Evaluation of novel agents for treatment of brain tumors
  • Developmental cancer therapeutics
  • Early translational therapeutics
Languages Spoken:
  • English
Google Map
  • University Neurologists
  • Professional Building
  • 1725 W. Harrison St.
  • Suite 1010
  • Chicago, IL  60612
  • Phone: (312) 563-3452
  • Fax: (312) 942-1783
  • View Larger MapDriving Directions

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

  1. Erratum to: Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme.
    Grossmann KF, Colman H, Akerley WA, Glantz M, Matsuoko Y, Beelen AP, Yu M, De Groot JF, Aiken RD, Olson JJ, Evans BA, Jensen RL.
    J Neurooncol. 2013
    2013 May
    113(1):151. doi: 10.1007/s11060-013-1118-2. No abstract available.
  2. Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme.
    Grossmann KF, Colman H, Akerley WA, Glantz M, Matsuoko Y, Beelen AP, Yu M, De Groot JF, Aiken RD, Olsen JJ, Evans BA, Jensen RL.
    J Neurooncol. 2012
    2012 Nov
    110(2):257-64. doi: 10.1007/s11060-012-0964-7. Epub 2012 Aug 30.

Find a Doctor | Patient & Visitor Services | Health Information | Clinical Services | Events & Classes | News Room | Clinical Trials | Research at Rush
Nursing at Rush | Work at Rush | Giving to Rush | Directions to Rush | Disclaimer | Privacy Statement
For Physicians | For Rush Employees | For Students | Bill Payment Center | Site Map
© Rush University Medical Center
1653 W. Congress Parkway, Chicago, Illinois 60612